Immune Responses from Bacterial Outer Membrane Vesicles in Vaccine Development
Author Information
Author(s): Velimirov Branko, Velimirov Branko Alexander, Fantini Jacques
Primary Institution: Private Sigmund Freud University, Medical Faculty, Division of Microbiology and Molecular Biology, Vienna, Austria
Hypothesis
Can outer membrane vesicles (OMVs) from Gram-negative bacteria be effectively used as vaccine platforms?
Conclusion
Outer membrane vesicles derived from Gram-negative bacteria can elicit protective immune responses and have potential as vaccine platforms with minimal side effects.
Supporting Evidence
- Outer membrane vesicles (OMVs) can carry a variety of antigens that stimulate immune responses.
- OMVs have been shown to induce protective immunity in animal models against various pathogens.
- Research indicates that OMVs can be engineered to enhance their vaccine potential while minimizing side effects.
Takeaway
Scientists are studying tiny bubbles made by bacteria that can help our bodies fight diseases, and they think these bubbles could be used to make vaccines.
Methodology
The review discusses the biogenesis of outer membrane vesicles, their antigenic properties, and their effects on the immune system based on existing literature.
Potential Biases
Potential bias in the interpretation of existing studies and the selection of literature reviewed.
Limitations
The review does not provide new experimental data and relies on existing literature, which may have varying quality.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website